Molnupiravir pill approved
This week the MHRA approved the antiviral treatment, molnupiravir, for use in the UK – making us the first country in the world to deploy an oral treatment for Covid-19 which can be taken at home.
- From the onset of the pandemic, the UK has lead the global effort in the research, development and rollout of the most cutting-edge treatments in the fight against Covid-19.
- Following approval by the MHRA, we will work at pace to deploy this game changing treatment to the most vulnerable and immunosuppressed across the country, with clinical trials showing it reduces the risk of hospitalisation and death for at-risk, non-hospitalised adults with mild Covid by 50 per cent.
- As we continue to bolster our defences against the virus, it is vital that everyone except those with specific medical reasons not to do so comes forward for their vaccine - or booster - so together we can save lives and protect our NHS.
If you have any reason to think the vaccine, booster or other medication might not be right for you or your family, don't just look at sources on the internet, here or anywhere else - please talk about it to an appropriately qualified medical professional such as your GP or pharmacist.